Skip navigation

Trader Talk

TRADER TALK VIDEO GALLERY

» More

Current DateTime: 05:48:28 24 Nov 2009
LinksList Documentid: 30483322
Expiration DateTime: 11/24/2009 5:51:22 AM

TRADER TALK RSS FEED

» Help

Current DateTime: 05:48:28 24 Nov 2009
LinksList Documentid: 30456179
powered by digg
Merger Monday
Published: Monday, 28 Sep 2009 | 9:46 AM ET
Text Size
By: Bob Pisani
Reporter

Bob Pisani is off today, this posting was written by CNBC producer Robert Hum.

Propelled by M&A activity and chatter, U.S. stock futures are up modestly this morning despite a sell-off in Asian markets overnight.

Japan’s Nikkei 225, Hong Kong’s Hang Seng, and China’s Shanghai Composite all fell over 2 percent as a weakening U.S. Dollar continued to weigh. The declining Dollar, which hit an 8-month low versus the yen, hurt shares of many Japanese exporters, as investors worried about the currency impact on forthcoming earnings.

As a result of today’s decline, the Nikkei 225 sits at a 2-month low, the Hang Seng Index rests at a 2-week low, and the Shanghai Composite hovers at a 3-week low.

Merger Monday Mania

Back in the U.S., M&A news dominates the headlines this morning:

1) Xerox [XRX  Loading...      ()   ] announced it will buy IT service provider Affiliated Computer Services [ACS  Loading...      ()   ] for $6.4 billion in cash and stock. The deal, which gives Affiliated Computer Services shareholders a nearly 34 percent premium on their shares, will give Xerox greater presence in the outsourcing/IT service industry with its services revenue seen tripling to $10 billion next year.

The merger is expected to close in the first quarter of next year. In pre-market trading, Affiliated Computer Services soars 21 percent, while Xerox falls 9 percent.

2) Abbott Laboratories [ABT  Loading...      ()   ] is up 3 percent pre-open after reaching a deal to acquire the pharmaceutical business of Belgian’s Solvay for $6.6 billion in cash. The acquisition will give Abbott full control over cholesterol-fighting drugs TriLipix and Tricor and will provide the drugmaker with an additional $3 billion in revenues worldwide. The deal should close early next year.

3) Dow component Johnson & Johnson [JNJ  Loading...      ()   ] revealed it has taken an 18 percent stake in Dutch biotech Crucell for $440 million. The deal creates a partnership that will help research and develop flu vaccines.

4) The U.K.’s Observer newspaper reports that Kraft [KFT  Loading...      ()   ] is looking at raising its offer for Cadbury [CBY  Loading...      ()   ] in a hostile bid. A new $17.6 billion deal would be about a 5 percent increase from its $16.7 billion cash and stock offer it made earlier this month.

_____________________________

_____________________________

Questions?  Comments? 


© 2009 CNBC, Inc. All Rights Reserved
Add This share icon
Text Size
ADD COMMENTS
Remaining characters


Current DateTime: 05:23:04 24 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 01:03:48 24 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 01:09:37 24 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:03:48 24 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters